Influence of Inhaler Compliance on the Treatment of Asthma Patients

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

The major goal of Influence of Inhaler Compliance on the Treatment of Asthma Patients is to explore compliance rate outcome in adult asthmatic patients (20-80 years old) with mild to moderate persistent asthma according to American Thoracic Society (ATS) definition and diagnosis. The major endpoints include: 1. To increase the adherence rate of treatment by reminder intervention with correctly monitor patients' adherence rate by Asthma Supportive Kits 2. Eventually achieve best asthma care and management. All participants will use Asthma Supportive Kits for 24 weeks and return visit on week 5, 12, 24. Based on collected data, the study compares intervention and control group to see if active reminder intervention may effectively alter compliance rate, and corresponding outcomes, e.g., asthma control status, acute exacerbation events.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: f
View:

• Adult asthmatic patients (20-80 years old)

• With mild to moderate persistent asthma according to ATS definition and diagnosis

• Willing to use Budesonide+Formoterol.

• Adequately use inhaler

• Without evident intentional non-adherence

• Agree asthma is a common and potentially serious chronic disease

• Willing to sign Informed Consent Form

Locations
Other Locations
Taiwan
Taipei Medical University, Taiwan, R.O.C.
RECRUITING
Taipei
Contact Information
Primary
Han-Pin KUO
hpk8828@gmail.com
+886975368066
Time Frame
Start Date: 2019-08-14
Estimated Completion Date: 2024-08-31
Participants
Target number of participants: 150
Treatments
Intervention Group
1. Patients (compliance rate \<80%) received active contact to remind on regular use of medication.~2. The intervention is engaged in caring aspect behavior. None of regular asthma treatment is altered between groups.
Control
Patients were not informed regardless to their compliance rate.
Related Therapeutic Areas
Sponsors
Collaborators: Taipei Medical University
Leads: Taipei Medical University Hospital

This content was sourced from clinicaltrials.gov